Expiry Date March 2024
SaNOtize Nasal Spray
Sanotize Nitric Oxide Nasal Spray (NONS) - Your Daily Protection Against VirusesBuy Now!
Already tested positive?
99% Reduction in COVID-19 Viral Load
Glenmark Phase III clinical trial shows reduction in SARS-CoV-2 log viral load by 94% within 24 hours, and by more than 99% in 48 hours.
Stay Safe Everywhere
Protect yourself from viruses at work or school, during meetings or when using public transportation and flights.
Gilly Regev and Chris Miller write about The Power of Nitric Oxide on MedCityNews.com
"The Power of NO: How a Tiny Natural Molecule Can Help Shift How We Treat...Read more
The Jerusalem Post: Can an anti-viral nasal spray stop Corona and other viruses?
"Enovid, an innovative anti-viral spray developed in Canada by an Israeli researcher and manufactured in...Read more
SaNOtize moves to carve a new market demand: over-the-counter prevention
There are currently zero authorized or approved preventative COVID therapies in the U.S. but Canadian...Read more
SaNOtize raised $24M to fund phase 3 trial of COVID-19 nasal spray
SaNOtize has raised a $24 million series B round, giving it the cash to fund its...Read more
Clinical Study Suggests SaNOtize Nitric Oxide Nasal Spray Is Effective at Preventing COVID-19 after High-Risk Exposure
Published on May 11, 2022 on Businesswire.com. After confirmed exposure to COVID-19, infection rate in...Read more
Phase 3 Clinical Trial Confirms SaNOtize’s Treatment is 99% Effective Against COVID-19
SaNOtize and Glenmark Pharmaceuticals Limited has announced on February 09, 2022: Phase 3 trial reached primary...Read more
Outstanding Preliminary Results of A Clinical Trial Treating Moderate-To-Severe Covid-19 Patients, Conducted By Amorphical, An Israeli Biotechnology Company
Amorphical, an Israeli biotech company developing Amorphous Calcium Carbonate (ACC) has announced results of a...Read more